Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk factors of small bowel obstruction following total proctocolectomy and ileal pouch anal anastomosis with diverting loop-ileostomy for ulcerative colitis.
Mizushima T, Kameyama H, Watanabe K, Kurachi K, Fukushima K, Nezu R, Uchino M, Sugita A, Futami K. Mizushima T, et al. Among authors: nezu r. Ann Gastroenterol Surg. 2017 Jun 12;1(2):122-128. doi: 10.1002/ags3.12017. eCollection 2017 Jun. Ann Gastroenterol Surg. 2017. PMID: 29863130 Free PMC article.
Advantages of laparoscope-assisted surgery for recurrent Crohn's disease.
Uchikoshi F, Ito T, Nezu R, Tanemura M, Kai Y, Mizushima T, Nakajima K, Tamagawa H, Matsuda C, Matsuda H. Uchikoshi F, et al. Among authors: nezu r. Surg Endosc. 2004 Nov;18(11):1675-9. doi: 10.1007/s00464-004-8802-4. Epub 2004 Oct 11. Surg Endosc. 2004. PMID: 15931478
[Three cases of colorectal cancer in patients with Crohn's disease].
Mizushima T, Nezu R, Ito T, Uchikoshi F, Kai Y, Tamagawa H, Matsuda C, Yamagami Y, Inoue Y, Matsuda H. Mizushima T, et al. Among authors: nezu r. Nihon Shokakibyo Gakkai Zasshi. 2005 Jul;102(7):912-7. Nihon Shokakibyo Gakkai Zasshi. 2005. PMID: 16038439 Review. Japanese. No abstract available.
A phase II study evaluating the feasibility of a 5-week cycle of S-1 plus irinotecan (IRIS) in patients with advanced and recurrent colorectal cancer.
Hata T, Fukunaga M, Murata K, Uemura Y, Fukuzaki T, Ota H, Ohue M, Ohnishi T, Tanaka N, Takemasa I, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M. Hata T, et al. Among authors: nezu r. Cancer Chemother Pharmacol. 2013 Jun;71(6):1657-63. doi: 10.1007/s00280-013-2143-8. Epub 2013 Mar 31. Cancer Chemother Pharmacol. 2013. PMID: 23543294 Clinical Trial.
A phase II study of combined chemotherapy with 5-week cycles of S-1 and CPT-11 plus bevacizumab in patients with metastatic colon cancer.
Mizushima T, Ide Y, Murata K, Ohashi I, Yasumasa K, Fukunaga M, Takemoto H, Tamagawa H, Hasegawa J, Hata T, Takemasa I, Ikeda M, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M. Mizushima T, et al. Among authors: nezu r. Oncology. 2013;85(6):317-22. doi: 10.1159/000356018. Epub 2013 Nov 12. Oncology. 2013. PMID: 24247419 Clinical Trial.
Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer.
Hasegawa J, Nishimura J, Mizushima T, Miyake Y, Kim HM, Takemoto H, Tamagawa H, Noura S, Fujii M, Fujie Y, Kato T, Miwa H, Takemasa I, Ikeda M, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M. Hasegawa J, et al. Among authors: nezu r. Cancer Chemother Pharmacol. 2014 May;73(5):1079-87. doi: 10.1007/s00280-014-2417-9. Epub 2014 Mar 5. Cancer Chemother Pharmacol. 2014. PMID: 24595805
153 results